Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins

Leukemia

Volumn 27, Issue 1, 2013, Pages 241-245

  Weston Bell, N J ^a   Hendriks, D ^a   Sugiyarto, G ^a   Bos, N A ^b   Kluin Nelemans, H C ^b   Forconi, F ^a   Sahota, S S ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; B RAF KINASE; CD103 ANTIGEN; CD123 ANTIGEN; CD19 ANTIGEN; CD27 ANTIGEN; CD5 ANTIGEN; GENOMIC DNA; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOCORTIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANTIGEN EXPRESSION; APOPTOSIS; B CELL LYMPHOMA; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CLINICAL FEATURE; DNA SEQUENCE; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HAIRY CELL LEUKEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LETTER; LEUKEMIA CELL LINE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOMATIC MUTATION; WESTERN BLOTTING;

EID: 84873566281     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.163     Document Type: Letter

References (27)

1. Matsuo Y, Sagawa K, Morita M, Minowada J, Yokoyama MM. Establishment of a hairy cell leukemia cell line carrying Tac antigen and phagocytic activity with B-cell characteristics. J Natl Cancer Inst 1986; 76: 207-216.
2. Kanowith-Klein S, Saxon A, Uittenbogaart CH. Constitutive production of B cell differentiation factor-like activity by human T and B cell lines. Eur J Immunol 1987; 17: 593-598.
3. Faguet GB, Satya-Prakash KL, Agee JF. Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines. Blood 1988; 71: 422-429.
4. Harvey W, Srour EF, Turner R, Carey R, Maze R, Starrett B et al. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation. Leuk Res 1991; 15: 733-744.
5. Schiller JH, Bittner G, Meisner LF, Oberley TD, Norback D, Schwabe M et al. Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient. Leukemia 1991; 5: 399-407.
6. Sasaki M, Aritaka N, Tsukune Y, Kawahara S, Masuda A, Tsutsui M et al. Establishment of a hairy cell leukemia variant cell line, HCLv-07. Acta Haematol 2009; 121: 63-66.
7. Genot EM, Meier KE, Licciardi KA, Ahn NG, Uittenbogaart CH, Wietzerbin J et al. Phosphorylation of CD20 in cells from a hairy cell leukemia cell line. Evidence for involvement of calcium/calmodulin-dependent protein kinase II. J Immunol 1993; 151: 71-82.
8. Harvey WH, Harb OS, Kosak ST, Sheaffer JC, Lowe LR, Heerema NA. Interferonalpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. Leuk Res 1994; 18: 577-585.
9. Nicolaou F, Teodoridis JM, Park H, Georgakis A, Farokhzad OC, Bottinger EP et al. CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD. Blood 2003; 101: 4033-4041.
10. Galiegue-Zouitina S, Delestre L, Dupont C, Troussard X, Shelley CS. Underexpression of RhoH in Hairy Cell Leukemia. Cancer Res 2008; 68: 4531-4540.
11. Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP et al. BRAF mutations in hairy-cell leukemia. N Engl J Med 2011; 364: 2305-2315.
12. Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 2012; 119: 192-195.
13. Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 2012; 119: 188-191.
14. Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood 2012; 119: 3330-3332.
15. Lennerz JK, Klaus BM, Marienfeld RB, Moller P. Pyrosequencing of BRAF V600E in routine samples of Hairy Cell Leukaemia identifies CD5\+ variant Hairy Cell Leukaemia that lacks V600E. Br J Haematol 2012; 157: 267-269.
16. Foucar K, Falini B, Catovsky D, Stein H. Hairy cell leukaemia. In: Swerdlow SH, Campo E, Harris NL et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008, pp 188-190.
17. Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004; 363: 1869-1870.
18. Sherman MJ, Hanson CA, Hoyer JD. An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol 2011; 136: 390-399.
19. Robbins BA, Ellison DJ, Spinosa JC, Carey CA, Lukes RJ, Poppema S et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82: 1277-1287.
20. Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 2004; 89: 303-308.
21. Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003; 16: 41-56.
22. Sainati L, Matutes E, Mulligan S, de Oliveira MP, Rani S, Lampert IA et al. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood 1990; 76: 157-162.
23. Suo A, Zhang M, Yao Y, Zhang L, Huang C, Nan K et al. Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2. Med Oncol 2011, e-pub ahead of print 7 July 2011; doi:10.1007/s12032-011-0013-y.
24. McArthur S, Cristante E, Paterno M, Christian H, Roncaroli F, Gillies GE et al. Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol 2010; 185: 6317-6328.
25. Forconi F, Raspadori D, Lenoci M, Lauria F. Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies. Haematologica 2005; 90: 266-268.
26. Weston-Bell N, Townsend M, Di Genova G, Forconi F, Sahota SS. Defining origins of malignant B cells: a new circulating normal human IgM(\+)D(\+) B-cell subset lacking CD27 expression and displaying somatically mutated IGHV genes as a relevant memory population. Leukemia 2009; 23: 2075-2080.
27. Weston-Bell NJ, Babbage G, Forconi F, Kluin-Nelemans HC, Sahota SS. Hairy cell leukaemia displaying multiple surface immunoglobulin isotypes reveal a functional B-cell receptor in which isotype roles differ. Blood (ASH Annual Meeting Abstracts) 2011; 118: 1567.